跳至主要内容
临床试验/IRCT2016091429822N1
IRCT2016091429822N1已完成2 期

Comparison of effects of Oxazepam, Valeriana officinalis, Lavandula angustifolia Mill and placebo on anxiety and sleep quality in patients with coronary artery disease

Vice-Chancellery for Research and Technology of Birjand University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • age between 30 to 70 years; willingness to participate in the study; no risk of heart failure (class III and IV) and cardiogenic shock; no use of complementary alternative medicine methods (herbal medicines and other methods) during the two weeks preceding intervention; no use of sleeping drugs, benzodiazepines, and sedative drugs; no addiction; no history of allergy to flowers, plants, valerian and lavender; no history of mental illness; stable vital signs; gaining a score of above 20 on the Spielberger's State and Trait Anxiety Inventory; obtaining a score equal to or over 5 on the Pittsburgh's Sleep Quality Index. Exclusion criteria: No cooperation during the study; sudden changes in the patient's hemodynamic status

排除标准

  • 未提供

研究者

发起方
Vice-Chancellery for Research and Technology of Birjand University of Medical Sciences

相似试验